Research Library

The top resource for free research, white papers, reports, case studies, magazines, and eBooks.

Share Your Content with Us
on TradePub.com for readers like you. LEARN MORE
The Obesity Drug Revolution

Request Your Free Trend Report Now:

"The Obesity Drug Revolution"

In this Trendline, we'll take an in depth look inside the booming weight loss drug market.

Known as GLP-1 agonists, new drugs could change how doctors treat obesity and, possibly, how the condition is more broadly understood. They could also raise healthcare spending substantially, posing a problem for insurers looking to control costs.

Included in this Trendline:

  • Wegovy approval for the heart broadens obesity drug use
  • Medicare cracks open coverage for Novo obesity drug
  • Novo pill could be company’s next entrant in obesity drug race


Offered Free by: BioPharma Dive and OPEN Health
See All Resources from: BioPharma Dive and OPEN Health

Recommended for Professionals Like You:

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.